1. Home
  2. AMTX vs MOLN Comparison

AMTX vs MOLN Comparison

Compare AMTX & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

N/A

Current Price

$1.16

Market Cap

134.2M

Sector

Industrials

ML Signal

N/A

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$3.48

Market Cap

137.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AMTX
MOLN
Founded
2005
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
134.2M
137.2M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
AMTX
MOLN
Price
$1.16
$3.48
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
★ $13.38
$10.11
AVG Volume (30 Days)
★ 686.6K
2.1K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 32.98
N/A
EPS
N/A
★ N/A
Revenue
★ $77,194,000.00
N/A
Revenue This Year
$24.86
N/A
Revenue Next Year
$44.09
$450.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 174.60
N/A
52 Week Low
$1.18
$3.51
52 Week High
$3.80
$5.36

Technical Indicators

Market Signals
Indicator
AMTX
MOLN
Relative Strength Index (RSI) 27.80 39.28
Support Level N/A N/A
Resistance Level $1.87 $4.19
Average True Range (ATR) 0.11 0.11
MACD -0.01 -0.00
Stochastic Oscillator 3.49 19.54

Price Performance

Historical Comparison
AMTX
MOLN

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: